Thalidomide (Thalomid) is an immunomodulatory drug used in the treatment of multiple myeloma.
SparkCures ID | 6 |
---|---|
Developed By | Celgene Corporation, a wholly owned subsidiary of Bristol Myers Squibb |
Brand Name | Thalomid® |
Generic Name | Thalidomide |
Treatment Classifications |
View all active clinical trials around the US.
The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.